Octreotide Injection bulk supplier for pharma manufacturers

Octreotide Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL

Reference Brands: Sandostatin.(EU & US)

Octreotide Injection (50 mcg/mL, 100 mcg/mL, 200 mcg/mL, 500 mcg/mL) is used in oncology to manage symptoms and control growth in carcinoid tumors, gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and acromegaly. Available in both U.S. and EU, this somatostatin analog is administered via subcutaneous or IV injection. It helps regulate hormone secretion, improving symptoms and tumor control in oncology patients, making it a key product in oncology B2B distribution.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Octreotide Injection 50 mcg/mL, 100 mcg/mL, 200 mcg/mL, and 500 mcg/mL is used to manage symptoms and control the growth of neuroendocrine tumors in oncology. Primarily indicated for carcinoid tumors, GEP-NETs, and acromegaly, Octreotide works by mimicking the effects of somatostatin, regulating hormone production. It is available in subcutaneous or IV formulations and is a vital part of oncology B2B distribution in both the U.S. and EU, ensuring better symptom management and tumor control for patients suffering from neuroendocrine malignancies and related conditions.

Octreotide Injection — third party manufacturing & bulk supply

Octreotide Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Octreotide Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Octreotide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Octreotide Injection →

Back to Listing

Frequently Asked Questions

Octreotide Injection is listed as Injection in 50 mcg/mL, 100 mcg/mL, 200,cg/mL, 500 mcg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Octreotide Injection is referenced against Sandostatin.(EU & US). Reference brands are shown for identification only and remain the property of their respective trademark owners.